A groundbreaking clinical trial is now seeking participants to test a treatment for combating Alzheimer’s-related memory loss. For healthy older adults looking to make a lasting impact in Alzheimer’s research, the A4 study could be a great opportunity.
According to Dr. Reisa Sperling, this is the first treatment designed to target individuals whose brains show the earliest changes of Alzheimer’s disease, but who have not yet begun to exhibit symptoms.
One such change is a buildup of a protein called amyloid, which forms plaques in the brain 10 to 20 years before significant memory loss occurs. This trial tests a treatment that is designed to help the brain clear amyloid.
One thousand qualified candidates are needed, and researchers are seeking 10,000 individuals between the ages of 65 and 85 to screen for this study. The sooner the trial gets underway, the sooner researchers will determine whether this drug could become an effective memory loss treatment. To see if you qualify for the study and to find a study location near you, check out the A4 website.
Watch the video to hear from Dr. Reisa Sperling, one of the world’s foremost Alzheimer’s researchers, about what makes the A4 study so groundbreaking, and why now is the time to participate.